| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |